Global Xanthan Gum Market will reach USD 1,269.6 Million in 2021: Zion Market Research
Nov 01, 2016 12:00 pm UTC| Business
Sarasota, FL, Nov. 01, 2016 -- Zion Research has published a new report titled “Xanthan Gum Market for Oil and Gas, Food and Beverage, Pharmaceutical, Cosmetics, and Other Applications - Global Industry Perspective,...
Gilat Unveils Revolutionary Small-Cell-Over-Satellite Solution for 3G and 4G Coverage
Nov 01, 2016 11:51 am UTC| Business
PETAH TIKVA, Israel, Nov. 01, 2016 -- Gilat Satellite Networks Ltd. (NASDAQ:GILT) (TASE:GILT), a worldwide leader in satellite networking technology, solutions and services, announced today its revolutionary CellEdge...
Nov 01, 2016 11:45 am UTC| Business
Ft. Lauderdale, FL, Nov. 01, 2016 -- Earth Science Tech, Inc. (ETST) (the “Company”), a publicly traded biotechnology company that develops, produces and sells nutraceutical products along with is its leading ETST...
Pluristem’s Pivotal Phase III Critical Limb Ischemia Trial Approved by UK Regulatory Agency
Nov 01, 2016 11:30 am UTC| Business
Pluristem expects to begin patient enrollment in the UK in first half of 2017 The trial will recruit in the U.S. and EU HAIFA, Israel, Nov. 01, 2016 -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading...
NetApp Introduces Solutions to Improve Control, Simplify Movement of Data in the Hybrid Cloud
Nov 01, 2016 11:30 am UTC| Business
SUNNYVALE, Calif., Nov. 01, 2016 -- "This is the cloud portfolio we were looking for; our lives couldn’t have been made simpler,” said Iain Rouse, group director—Cloud, TechnologyOne. “After a flood caused a three-day...
Nov 01, 2016 11:30 am UTC| Business
CHAPEL HILL, N.C., Nov. 01, 2016 -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases,...
Amicus Therapeutics to Announce Third Quarter 2016 Financial Results on November 7, 2016
Nov 01, 2016 11:30 am UTC| Business
CRANBURY, N.J., Nov. 01, 2016 -- Amicus Therapeutics (Nasdaq:FOLD), a biotechnology company at the forefront of therapies for rare and orphan diseases, today announced a conference call and live audio webcast on Monday,...